Prerpints.org logo
Preprint
Article

Oral Spirochete Treponema denticola Intraoral Infection Reveals Unique miR-133a, miR-486, miR-126-3p, miR-126-5p miRNA Expression Kinetics during Periodontitis

This version is not peer-reviewed.

Submitted:

12 July 2023

Posted:

13 July 2023

You are already at the latest version

A peer-reviewed article of this preprint also exists.

Abstract
miRNAs are major regulators of eukaryotic gene expression, host immunity, and play an important role in the inflammation-mediated pathways in periodontal disease (PD) pathogenesis. Expanding our previous observation with the global miRNA profiling using partial human mouth microbes and lack of in vivo studies involving oral spirochete Treponema denticola induced miRNAs, this study was designed to delineate the global miRNA expression kinetics during progression of periodontitis in mice infected with T. denticola by using NanoString nCounter® miRNA panels. All the T. denticola-infected male and female mice at 8- and 16 weeks demonstrated bacterial colonization (100%) on the gingival surface, and an increase in alveolar bone resorption (p < 0.0001). A total of 70 miRNAs with at least 1.0-fold differential expression/regulation (DE) miRNAs (26 upregulated and 44 downregulated) were identified. nCounter miRNA expression profiling identified 13 upregulated miRNAs (e.g. miR-133a, miR-378) and 25 downregulated miRNAs (e.g. miR-375, miR-34b-5p) in T. denticola-infected mice mandibles during 8-weeks infection whereas 13 upregulated miRNAs (e.g. miR-486, miR-126-5p) and 19 downregulated miRNAs (miR-2135, miR-142-3p) were observed during 16- weeks of infection. One miRNA (miR-126-5p) showed significant difference between 8-and 16-weeks of infection. Interestingly, miR-126-5p has been presented as a potential biomarker in patients with periodontitis and coronary artery disease. Among the 13 upregulated miRNAs, miR-486, miR-126-3p, miR-126-5p were reported in human gingival plaques samples with periodontitis. KEGG analysis revealed various functional pathways of DE miRNAs such as bacterial invasion of epithelial cells, Ras signaling, Fc gamma R- mediated phagocytosis, osteoclast differentiation, adherens signaling and ubiquitin mediated proteolysis. This is the first study of DE miRNAs in mice mandibles at different time-points of T. denticola infection and the combination of three specific miRNAs miR-486, miR-126-3p, miR-126-5p may serve as an invasive biomarker of T. denticola in PD. These miRNAs may have significant role in PD pathogenesis and establishes a link between miRNA, periodontitis, and systemic diseases.
Keywords: 
Subject: 
Biology and Life Sciences  -   Immunology and Microbiology

supplementary.docx (415.98KB )

1. Introduction

The microRNAs (miRNAs, miR) are widely recognized as key regulators of various biological processes and have physiological functions in modulating expression of many important genes [1]. Last two decades, there has been significant progress in miRNA research and miR have been linked to numerous human diseases (cardiovascular disease, HIV, diabetes, hypertension, cancer). Currently, more than 2000 miRNAs have been identified in humans, and they collectively regulate one-third of the genes in the genome [2]. Each specific miRNA can have hundreds of different targets that affect entire gene expression networks [3]. miRNAs have been implicated in many diseases and regulate the immune response of hosts infected with bacteria such as Treponema pallidum [4], Helicobacter pylori [5], Mycobacterium avium [6], M. tuberculosis [7], Salmonella [8], and Listeria monocytogenes [9]. Hence, understanding the expression pattern of miRNAs could potentially lead to the development of novel diagnostic biomarkers for various complicated microbial infection driven inflammatory diseases including periodontal disease (PD). PD is a dysbiotic chronic inflammatory disease caused by microbes interacting in the human subgingival sulcus. Interaction of various bacteria in the human subgingival sulcus results in host abnormal immune response specifically inflammatory response leading to infectious gingivitis, periodontitis, characterized by resorption of the alveolar bone and tooth loss [10].
Several inflammatory miRNAs such as miR-21 [11], miR-146a [12,13] , miR-155 [14,15] and miR-132 [16] were reported to be involved in the initiation and progression of PD. However, none of these inflammatory miRNAs were differentially expressed (DE) in a recent report that deployed partial human mouth microbes (PAHMM) in an ecological time-sequential polybacterial infection mouse model (ETSPPI) [17]. This observation suggested that various miRNAs are involved in PD and the miRNA expression pattern may be bacterium-specific and time-dependent. T. denticola is a major spirochete commonly colonized in the subgingival cavity and strongly implicated in PD. Though it resides in the gingival sulcus, high proportions of T. denticola were observed in the subgingival space in patients with gingivitis and periodontitis [18,19]. Recent reports with periodontitis and gingivitis patients’ subgingival plaques revealed the presence of highly taxonomically diverse communities of treponemes [20]. The virulence factors (chymotrypsin-like protease, phospholipase C, oligopeptidase, and endopeptidase) from T. denticola can disrupt the epithelial cells and stimulate host-immune responses [18] and induces interleukin-36γ expression in human oral gingival keratinocytes [21]. After its stimulation, T. denticola can successfully activate the host innate immune response in a TLR2-dependent fashion [22] enter the circulatory system and colonize in the distal organs [23,24]. We have reported the intracellular localization of viable T. denticola in gingiva, salivary glands, and the aorta. We have also reported its genomic DNA in the aortic tissues and identified inflammatory mediators in the serum of the mice after T. denticola infection [25]. Studies have identified the presence of T. denticola DNA in the atheromatous plaques of atherosclerotic patients [26,27]. T. denticola was detected in metagenomic analysis of ancient human bone tissue biopsies from Otzi the Iceman, a 5,300-year-old Copper Age natural ice mummy, giving credence to hematogenous dissemination of this periodontal spirochete [28]. T. denticola has also been closely linked with Alzheimer’s Disease (AD) and recent in vivo studies have shown the tau hyperphosphorylation by T. denticola [29]. Furthermore, this is the first study that used a high-throughput approach in exploring altered miRNA profiles from T. denticola-infected mouse gingival tissues at two time-points (8-weeks and 16-weeks) and sham-infected normal tissues.
To date, the role of miRNAs in response to T. denticola live infection in mouse model of PD has not been explored. The aims of this study were to determine whether intraoral infection of mice with T. denticola could lead to the global alteration of miRNAs expression patterns, and assess the link between miRNAs and T. denticola–induced gingival inflammation. A systematic investigation of the miRNA expression profiles in mice mandibles of T. denticola-infected C57BL/6J mice during 8- and 16-weeks compare with uninfected mice was conducted using the high-throughput NanoString nCounter® miRNA expression panels. Gingival infection of T. denticola significantly increased ABR. We reported T. denticola colonization of the gingival surface on all the mice and a significant increase in ABR at 8-weeks and 16-weeks duration of infected mice. Unique miRNAs were identified in both 8-weeks and 16-weeks T. denticola-infected mice. Only one miRNA, miR-126-5p was commonly expressed at both time-points. This study provides increased understanding of the specific miRNA signature of T. denticola in a PD mouse model.

2. Results

2.1. Effective colonization of T. denticola in mouse gingival tissues

Oral gingival plaque samples from mice after T. denticola infection were used for 16S rRNA gene specific colony PCR and it demonstrates the presence of T. denticola 16S rRNA gene amplicon in agarose gel electrophoresis. After the first infection cycle, only one mouse from each of the 8-weeks and 16-weeks infected group was positive for T. denticola gDNA. However, all the mice (100%) tested positive for T. denticola after the second infection cycle (Table 1). None of the sham-infected mice were positive at any point for genomic DNA of T. denticola. These results confirmed the colonization of the T. denticola in both 8-weeks and 16-weeks T. denticola-infected group.

2.2. T. denticola infection increased alveolar bone resorption with minimal dissemination of treponems to distal organs

Periodontal disease outcome of the bacterial infection was examined using bone morphometry by measuring the horizontal ABR. Mice at both 8-weeks and 16-weeks infection with T. dentiola showed significantly higher ABR in the mandible (lingual) (Adjusted p-value= 0.0004 for 8-weeks group; p < 0.0001 for 16-weeks group) (Figure 1B-C). Similarly significantly higher ABR was observed in the maxilla (palatal) (p < 0.0001 for 16-weeks T. denticola infected mice. No IgG antibody response was observed against T. denticola in both 8-weeeks and 16-weeks infected mice (data not shown). 40% of the female mice infected with T. denticola at 16-weeks demonstrated bacterial disemination in their lung tissues. (Table 2). Robust bacterial dissemination to other distal organs such as the heart, brain, liver, kidney and spleen was not observed.

2.3. Nanostring analysis of miRNAs in T. denticola -infected mandibles

Global miRNA profiling was carried in the mice mandibles infected with T. denticola at 8-weeks and 16-weeks infection. A p-value of >0.05 and fold change (FC) of 1.1 was taken for analysis and considered to be significant. A total of 70 differentially regulated miRNAs were identified. nCounter miRNA expression profiling showed 13 upregulated miRNAs (e.g. miR-133a, miR-378) and 25 downregulated miRNAs (e.g. miR-375, miR-34b-5p) in T. denticola infected mice mandibles compared to sham-infected mice mandibles during 8 weeks infection. Thirteen upregulated miRNAs (e.g. miR-486, miR-126-5p) and 19 downregulated miRNAs (miR-2135, miR-142-3p) were identified in T. denticola infected mice compared to sham-infected mice during 16 weeks infection (Table 3; Supplementary Table S1 to S3). Volcano plot analysis identified 9 upregulated and 18 downregulated miRNAs in 8 weeks-Td infected group (Figure 2A). miR-126-5p was the only one commonly upregulated miRNAs in 8- and 16-weeks-infected T. denticola mice mandibles and all the DE miRNAs were unique to the specific time-point (Figure 2B). Inflammatory miR-132 (FC 1.21; p-value:0.01) was upregulated in 16-weeks infected mice mandibles but it was not upregulated in 8-weeks infected mice mandibles. Other previously identified inflammatory miRNAs such as miR-146a, miR-132, and miR-155 were not differentially expressed at both the time-points.

2.4. Functional pathways analysis of Differentially expressed miRNAs

Predicted functional pathway analysis of the DE miRNAs in both 8-weeks and 16-weeks T. denticola-infected mice identified several pathways (DIANA-miRPath) Hippo signaling, mitogen-activated protein kinase (MAPK) signaling pathway, Wnt (Wingless and Int-1) signaling pathway, pathways related to various cancers such as pancreatic cancer, small cell lung cancer and prostate cancer. Further, 14 significantly DE miRNAs expressed in 8-weeks and 16-weeks T. denticola infected mice were found to be involved in bacterial invasion of epithelial cells in signaling pathway (Figure 3 and Figure 4, Table 5). Similarly, DE genes involved with the TNF signaling pathway was associated with leucocyte recruitment, activation and increased inflammatory cytokine expression genes (Supplementary Figure S1). In addition, other pathways that are linked with infection and host cell associations such as adherens junctions, endocytosis, TNF signaling, apoptosis were also identified. Literature review of the identified upregulated miRNAs in 8-weeks and 16-weeks T. denticola-infected mice revealed that the commonly expressed miRNA-126-5p at both the time-points was shown to be overexpressed in ovarian cancer cells [30], endothelial proliferation, atherosclerosis [31] and in ischemic stroke [32]. Another inflammatory miRNA miR-132 was shown to inhibit differentiation of periodontal ligaments cells into osteoblasts [33]. Detailed reported functions of the upregulated miRNAs are shown in Table 4. The number of target genes for each upregulated miRNAs in 8- and 16- weeks of infection was analyzed using miRTarBase. We used mmu-miR-133 an example for an upregulated DE miRNA during 8 weeks of infection in identifying the target genes. T. denticola-infection induced mmu-miR-133 that has 28 different target genes with 28 different MiRTarBase ID as shown in supplementary Table S4. Similarly, we used mmu-miR-486 an example for an upregulated during 16 weeks of infection in identifying the target genes. T. denticola-infection induced mmu-miR-486 that has 41 different target genes with 41 different MiRTarBase ID as shown in supplementary Table S5.

3. Discussion

Recent studies using partial human mouth microbes (PAHMM) in ecological time-sequential polybacterial periodontal infection model (ETSPPI) showed sex-specific differential miRNA expression during PD [17]. This PD mouse model utilized five different bacteria such as Streptococcus gordonii (early colonizer), Fusobacterium nucleatum (intermediate colonizer) and Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia (late colonizers). Though we have developed highly efficient 5 multi-species infection-induced miRNAs expression, but studies on the role of DE miRNAs to monobacterial infection has not been performed. Hence, we designed this study to analyze the global miRNA expression patterns at two different time-points in T. denticola-induced PD. We analyzed T. denticola colonization on the mice gingival surface, horizontal ABR measurements, intravascular dissemination of T. denticola to distal organs and global miRNA profiling in T. denticola mice infected at 8- and 16-weeks infection. All the mice infected with T. denticola at both the time-points showed 100% bacterial colonization on the gingival surface which was confirmed via 16S rRNA gene amplification. Significantly higher ABR was also observed in T. denticola infected mice at both time-points. This data was in line with our previously published data where significantly higher ABR was observed in TgCRND8 mice and ApoE-/- mice infected with T. denticola through gingival infection [68]. Similarly, the observed ABR data was also consistent with our recent study using PAHMM infected ETSPPI mouse model [17]. Based on the observed significant ABR in both 8- and 16-weeks infection, we once again confirmed that T. denticola is one of the major periodontal bacteria in the progression of PD.
miRNA profiling of mice mandibles infected with T. denticola identified unique miRNA gene signatures with both 8- and 16-weeks infection. Most of the DE miRNAs were unique and specific to each time-point and confirmed that miRNA expression is transient and time-dependent. The DE miRNAs in 8-week infected mice was not found in the 16-week infected mice. Though all the DE miRNAs were unique, miR-126-5p was commonly upregulated at both time-points. It is interesting that miR-126-5p has been observed in gingival tissues in periodontitis patients [12,15]. Further, miR-126-5p has been shown as a potential biomarker in patients with periodontitis and coronary artery disease [27]. miRNA-126-5p has been found to play a dual role in the atherosclerotic pathway in which it prevents plaque formation by downregulating VCAM-1 expression and augments the atherosclerotic process through muscle cell proliferation and activation [27]. In addition, miR-126-5p plays a major role in ovarian cancer by promoting chemoresistance of ovarian cancer cells [30] and attenuates the blood-brain barrier after ischemic stroke [32]. As miR-126-5p was upregulated at both time-points, it may be considered as a potential biomarker for PD.
Among the 13 upregulated miRNAs (e.g., miR-133a (1,83 FC; miR-378 (1.57 FC) in the 8-weeks T. denticola-infected mice, none of the miRNAs were shown to be observed in human periodontitis gingival plaque samples. However, among the 13 upregulated miRNAs in 16-weeks T. denticola-infected mice, three miRNAs viz. miR-486, miR-126-3p, miR-126-5p were reported in human gingival plaques samples with periodontitis [12,15,42,56]. miR-133 has therapeutic application in heart disease as a key regulator of cardiac hypertrophy [69], a protective effect against myocardial ischemia-reperfusion (IR) injury in Sprague Dawley rats, [70] and improves cardiac function and fibrosis via inhibiting Akt in heart failure rats [71]. miR-486 was also reported to promote cardiac angiogenesis through fibroblastic MMP-19-VEGFA cleavage signaling pathway [53]. Treponema species possess lipopolysaccharides on their outer membrane [72] and elevated miR-486-5p observed during acute lung injury in human subjects and LPS-induced acute lung injury in mice [73]. Elevated miR-486-5p has been reported to prevent endothelial dysfunction through anti-inflammation and anti-oxidant mechanisms [74]. miR-126-3p was significantly overexpressed in gingival tissues of chronic and aggressive periodontitis. miR-126 is also associated with other inflammatory disease conditions such as obesity and arthritis [75]. Since, these three miRNAs were observed in both human periodontal gingival tissues and T. denticola induced experimental periodontitis, further in-depth analysis are needed to consider miR-486, miR-126-3p, miR-126-5p as potential biomarkers for periodontal disease.
Another inflammatory miR-132 was also upregulated during 16-weeks T. denticola infection. We have previously shown that THP-1 cells infected with live and heat-killed T. denticola did not significantly increase miR-132 expression. Thus, the observed miR-132 expression under in vivo conditions suggest that miR-132 expression may vary under in vitro and in vivo conditions and further validation needs to be performed to confirm this observation [16]. Other widely reported inflammatory miRNAs miR-155 and miR-146a was not upregulated in both 8- and 16-weeks T. denticola-infection. Other upregulated miRNAs such as miR-378, miR-22, miR-451, miR-496, miR-151-5p, miR-101a, miR-423-5p and miR-221 were found to be closely associated with various human cancers. miR-378 plays a major role in hepatic inflammation and fibrosis by targeting NFκB-TNFα axis [35]. miR-22 promotes cell differentiation, tumor initiation, progression and metastasis by maintaining Wnt/β-catenin signaling and cancer stem cell function [37]. miR-451 plays an important role in lung tumor progression and is highly dysregulated in lung cancer [41]. miR-496 mediates tumor metastasis in colorectal cancer through Wnt signaling pathways [45]. Further, miR-423-5p was noted to be overexpressed in breast cancer causing severe invasion of tumor cells through NFκB signaling pathway [61]. Thus, most of the upregulated miRNAs during T. denticola-infection may be involved in tumor progression and metastasis by mediating NFκB pathway, TNF signaling or Wnt signaling pathways. It is obvious that the upregulated miRNAs in the current study may have these functions as it is involved in the inflammatory mediated periodontal infection which leads to NFκB activation for transcription of inflammatory genes.
Several reports have identified a link between T. denticola and various brain disorders such as AD and stroke [76,77,78,79] . Interestingly, the upregulated miR-101b was found to play an important mediator of tauopathy and dendritic abnormalities in AD progression [62]. Further, miR-136 was identified as a potential biomarker for human mild traumatic brain injury [39]. These reports strongly suggest a possible link between bacteria induced gingival and cerebral inflammation via miR-101b and miR-136. The other upregulated miR-30a and -30c was observed to be highly expressed in gingival tissues in periodontitis patients that plays a major role in inhibition of osteogenesis followed by periodontitis [43,44].
Predicted functional analysis pathways using KEGG revealed interesting findings. Most of the pathways targeted by the miRNAs that were differentially expressed during T. denticola were linked to bacterial pathogen recognition and clearance including endocytosis, bacterial invasion of cells, and FcR-mediated phagocytosis. Further, 14 miRNAs were found to be closely associated with bacterial invasion of epithelial cells. This is the first study that identified the specific miRNAs involved in T. denticola invasion of epithelial cells that could be potentially used as biomarkers for periodontitis. Other pathways linked with infection and host-cell associations such as adherens junctions, endocytosis, TNF signaling, lysosome, and TGF-β signaling pathways were also identified. Recent clinical study identified functional circRNAs and prediction of circRNA-miRNA-mRNA regulatory network in periodontitis [80]. To conclude, this is the first study that reported the global miRNA expression kinetics to T. denticola infection. This study highlights the transient expression of miRNA in mouse gingival tissues and their expression pattern varies based on the length of T. denticola infection. Further, in-depth analysis on the identified DE miRNAs using KO mouse models will provide additional details on PD pathogenesis and its link with other systemic diseases.

4. Materials and Methods

4.1. Gingival infection of T. denticola to induce periodontitis in C57BL/6J mouse

T. denticola ATCC 35405 (Td) was grown in GM-1 broth in anaerobic growth chamber at 37 °C for three days. The log phase culture of T. denticola was harvested after centrifugation at 8000 rpm for 10 minutes followed by washing with sterile 5 ml Phosphate buffered saline (PBS). The pellets were resuspended in equal volume of 3% Carboxymethylcellulose and reduced transport fluid (RTF). 100 µl of bacterial suspension was taken for gingival infection. Both male and female mice were divided into four groups (n=10) (Group-I: Td-infected-8 weeks; Group-II: Td-infected-16 weeks; Group-III: Sham-infected-8 weeks; Group-IV: sham-infected-16 weeks). Bacterial infection was performed in each group of mice for 8- and 16-weeks (infection cycle consists of four days per week for every alternative week to induce chronic periodontitis (Figure 1 a). An equal volume of RTF and CMC was used as a vehicle control for sham-infected mice as described previously [17,25,68]. Kanamycin (500 mg/ml) was administered in sterile drinking water for three days to suppress the existing mouse oral bacteria followed by rinsing with 0.12% of Chlorhexidine gluconate. After antibiotic washout period, the mice were given topical gingival infection of T. denticola (108 cells each). [17,68,81,82]. Mice were euthanized after 8 weeks and 16-weeks of infections. Left mandibles and maxilla were stored in RNAlater (Invitrogen, Waltham, MA, USA) until total RNA extraction and all other distal organs such as brain, heart, lung, spleen, liver and kidney were also collected. Right maxilla and mandibles were collected for bone morphometry measurements. Blood was collected through cardiac puncture and the serum was stored at -20 °C for serum IgG analysis. All the animal procedures were done according to the guidelines framed by the University of Florida Institutional Animal Care and Use Committee (IACUC protocol number 202200000223).

4.2. T. denticola 16S rRNA gene amplification in oral plaques

Gingival plaque samples from the mice infected with T. denticola and sham-infection were collected after four continuous days of infection by using sterile cotton swabs. T. denticola gDNA was detected using 16S rRNA gene species-specific primer of the bacteria using Phusion High Fidelity Master Mix from New England Biolabs (NEB, Ipswich, MA, USA) as described previously [83,84,85,86]. Briefly, colony PCR was performed with a Bio-Rad Thermal Cycler using T. denticola -specific 16S rRNA gene-specific forward primer 5’-TAATACCGAATGTGCTCATTTACAT-3’, reverse primer 5’-CTGCCATATCTCTATGTCATTGCTCTT-3’. Genomic DNA extracted from the T. denticola was used as a template for positive control and samples with no bacterial DNA were used as a negative control. PCR products were run on 1% agarose gel electrophoresis and visualized under UVP GelStudio touch Imaging System (Analytik Jena US LLC, CA, USA) [17,68].

4.3. Bacterial systemic dissemination to distal organs

Genomic DNA from an aliquot of the distal organs such as heart, lungs, liver, brain, kidney and spleen from 16-weeks infected mice and sham-infection were extracted following a standard procedure described in the Qiagen Dneasy Blood and Tissue kit (Qiagen, Germantown, MD, USA). T. denticola specific 16S rRNA gene-specific PCR was performed to confirm the presence of T. denticola gDNA in the distal organs. [83,84,85,86].

4.4. Horizontal alveolar bone resorption by morphometry

The horizontal ABR area of T. denticola-infected and sham-infected mice was measured by histomorphometry as described previously [83,84,85,86]. The right mandibles and maxilla of the infected and sham-infected mice were autoclaved for 20 min. The autoclaved mandibles and maxilla were defleshed followed by incubation at 3% hydrogen peroxide for 30 min and air dried. Two-dimensional mandibles and maxilla molar teeth images were captured using a stereo dissecting microscope (Stereo Discovery V8, Carl Zeiss Microimaging, Inc, Thornwood, NY, USA). The area between the cemento-enamel junction to the alveolar bone crest of the buccal and palatal surfaces of the maxillary jaws and lingual mandibular jaw was measured by using the line tool (AxioVision LE 29A software version 4.6.3, Thornwood, NY, USA). Two examiners blinded to the T. denticola mice groups measured the ABR [17,25,68,87].

4.5. nCounter® miRNA expression profiling using NanoString analysis

Mandibles (left; n=10) from each mouse (four groups) were taken for NanoString analysis. The total RNA from each mandible was extracted based on the protocol described in the mirVana miRNA isolation kit (Ambion, Austin, TX, USA) and described in our recent publications [88]. Briefly, mandibles from each mouse were homogenized using the handheld rotor-stator homogenizer with sterile individual TissueRuptor disposable probes (Qiagen; Germantown, MD, USA) for each specimen. After homogenization, each homogenized tissue was lysed in a denaturing lysis solution that stabilized RNAs and inactivated RNases. The lysed tissue samples were subjected to an acid-phenol:chloroform extraction that removed all the cellular components (protein, DNA, and other cellular products). The aqueous phase was removed and 1.25 volume of 100% ethanol was added. This was transferred to the filter cartridge placed into the collection tube and centrifuged for 15 s at 10,000× g. This cartridge was washed with Wash solution-1 and Wash solution-2/3. The total RNA was eluted from the filter cartridge with nuclease-free water. The RNA concentration and purity were assessed using a Take3 micro-volume plate in Epoch Microplate Spectrophotometer (BioTek, USA, Winooski, VT, USA) and RNA quantification was performed in technical duplicates for each specimen.
High-throughput nCounter® miRNA Expression Panels (Nanostring Technologies, Seattle, WA, USA) was used to study the DE of miRNA in 8-weeks and 16-weeks infected and sham-infected male and female mice as detailed in [88]. Nanostring nCounter® panel can identify 577 miRNAs in any RNA specimen, and by using molecular barcodes, Nanostring can detect even a small number of miRNAs without the need for reverse transcription or amplification. Mouse miRNA expression profiling was performed using the Nanostring nCounter® Mouse miRNA Assay kit v1.5 (Nanostring Technologies). This assay is a highly sensitive multiplexed method that detects miRNAs using molecular barcodes called nCounter reporter probes without the need for reverse transcription. Specimen preparation involving annealing, ligation, and purification were performed based on the experimental procedure described in the nCounter® miRNA assay panel kit and described in our recent report [88]. Briefly, the annealing master mix was prepared by combining annealing buffer, nCounter miRNA Tag reagent, and diluted miRNA assay controls. Further, the annealing master mix was aliquoted into each tube of the strip and 100 ng of the total RNA from ten mandibles from each group was added to the respective tubes. The strip tube was transferred in the Thermal Cycler with the following conditions: 94 ⸰C for 1 min, 65 ⸰C for 1 min, 45 ⸰C for 1 min, and 48 ⸰C for hold.
Following annealing, ligation master mix (polyethylene glycol (PEG) and ligation buffer) was added in the strip tube. The strip tube was incubated, followed by the addition of ligase into tube. The ligation was performed with the following conditions: 48 ◦C for 3 min, 47 ◦C for 3 min, 46 ◦C for 3 min, 45 ◦C for 3 min, 65 ◦C for 10 min, and 4 ◦C for hold. To separate the unligated tags, a purification step was performed after adding ligation cleanup enzyme and incubating at 37 ◦C for 1 h, 70 ◦C for 10 min, and 4 ◦C for holding. The RNase-free water was added in the strip tube and the specimen was ready for hybridization with the nCounter reporter and capture probes. After denaturation, an aliquot from the miRNA sample preparation tube was taken along with the miRNA reporter code, hybridization buffer, and miRNA capture probe. The strip tubes were incubated in the Thermal cycler, and the specimens were immediately processed for post-hybridization with the nCounter analysis system at the Molecular Pathology Core at the University of Florida [88] . The nCounter® Mouse miRNA Assay kit v1.5 provided six positive hybridization controls and eight negative control probes to monitor hybridization efficiency. All components and reagents needed for specimen preparation at the reparation station were taken from the nCounter master kit. Twelve specimens per cartridge were processed in a single run and followed by digital analysis, which involved the transfer of the cartridge to the multichannel epifluorescence digital analyzer. A cartridge definition file with a maximum fields of view (FOV) count of 555 per flow cell was taken for digital analysis. The number of images taken per scan corresponded to the number of immobilized reporter probes on the cartridge. A separate Reporter Code Count (RCC) file for each sample containing the count for each probe was downloaded and used for miRNA data analysis [17].

4.6. NanoString data analysis

Initial data analysis was performed using nSolver 4.0 as described previously [88]. After importing the RCC files to the nSolver, stringent quality measures were taken as per the system recommendations. All the 40 specimens passed the QC and no flag lanes were observed. Raw data were generated after passing the QC. To reduce the background signal/noise, the background threshold count value was set as 52 and calculated by taking an average of eight negative control probe counts from all 40 samples. miRNA gene normalization was done based on the top 100 miRNA genes expressed. The normalized factor was calculated based on the geometric mean values of the miRNA expressed in each specimen. All the normalized data were analyzed further using ROSALIND (https://rosalind.bio/), with a HyperScale architecture developed by ROSALIND, Inc. (San Diego, CA) [89]. Fold changes in the genes were calculated based on the ratio of the difference in the means of the log-transformed normalized data to the square root of the sum of the variances of the specimens in the groups. For KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis, we analyzed the DE miRNAs in 8- and 16-weeks bacterial infected mice mandibles in DIANA-miRPath v.3.0 database [90]. All the DE miRNAs were entered using the MIMAT accession number in the DIANA-miRPath v3.0 database with the threshold values of p<0.05 and false discovery rate (FDR) correction applied to obtain unbiased empirical distribution, bacterial invasion of epithelial cells pathway, and TNF signaling pathway. Additionally, we analyzed the DE miRNAs in 8- and 16-weeks bacterial infected mice mandibles in miRTarBase which is the experimentally validated microRNA-target interactions database (miRTarbase update 2022: an informative resource for experimentally validated miRNA-target intercations) [91]. Venn diagram for upregulated and downregulated miRNAs in 8- and 16-weeks infection group was drawn using Venny 2.1 as described previously [88].

4.7. Statistical analysis

An ordinary two-way ANOVA with Turkey’s multiple comparisons was performed for multiple group comparison to determine the statistical significance using the statistical software Prism 9.4.1 (GraphPad Software, San Diego, CA, USA). All the data in graphs are presented as mean + SEM. Two-tailed t-testing was performed on the log-transformed normalized data that assumed unequal variance to identify the differential gene expression as described previously [88]. A p-value of < 0.05 was considered to be statistically significant.

5. Conclusions

This is the first oral spirochete T. denticola monobacterial infection in vivo study that reports the altered global miRNA kinetics in experimental periodontitis. This study found that the elevated miR-133a (1.8 FC) expression in mice mandibles during 8-weeks may play an important function in the initial immune response to T. denticola infection. Unique miRNAs were identified in both 8- and 16-weeks T. denticola infection. One miRNA (miR-126-5p) showed significant difference between 8-and 16-weeks infection and controls. It is interesting to note that miR-126-5p has been shown as a potential biomarker in patients with periodontitis and coronary artery disease. KEGG pathway analysis of the DE miRNAs revealed various functional pathways. Our study provides strong insights on the specific miRNA signature (periodontitis biomarkers) of T. denticola in PD mouse model at two different time-points. However, reservations must be made before transposing this model to the complexity of periodontal disease in humans.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org.

Author Contributions

C.A. performed all the mouse experiments, analyzed the data, and wrote the initial draft of the manuscript. S.J. performed miRNA KEGG pathway and target gene analyses. K.M.V. done the molecular analysis of distal organs dissemination of T. denticola by PCR. R.B.E. assisted in the morphometry analysis. L.K. was responsible for all experimental design and critically revising the entire manuscript. L.K., C.A., and S.J. were involved in the final revision and editing the manuscript. L.K. and E.K.L.C. are the Principal Investigators of the NIH (NIDCR) study. All authors gave their final approval and agreed to be accountable for all aspects of the work. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the NIH National Institute of Dental and Craniofacial Research (NIDCR) (R01 DE028536) to L. Kesavalu and E.K.L. Chan. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.

Institutional Review Board Statement

All animal procedures were approved by the University of Florida Institutional Animal Care and Use Committee (IACUC) under protocol number 202200000223.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are openly available in NCBI at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235373.

Acknowledgments

The authors acknowledge Andreas Gonzalez, M.D., for previewing and editing the manuscript.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281–297. [Google Scholar] [CrossRef]
  2. Faulkner, J.L.; Sullivan, J.C. Circulating cell-free micro-RNA as biomarkers: from myocardial infarction to hypertension. Clin Sci (Lond) 2022, 136, 1341–1346. [Google Scholar] [CrossRef] [PubMed]
  3. Tam, S.; de Borja, R.; Tsao, M.S.; McPherson, J.D. Robust global microRNA expression profiling using next-generation sequencing technologies. Lab Invest 2014, 94, 350–358. [Google Scholar] [CrossRef] [PubMed]
  4. Huang, T.; Zhang, J.; Ke, W.; Zhang, X.; Chen, W.; Yang, J.; Liao, Y.; Liang, F.; Mei, S.; Li, M.; et al. MicroRNA expression profiling of peripheral blood mononuclear cells associated with syphilis. BMC Infect Dis 2020, 20, 165. [Google Scholar] [CrossRef] [PubMed]
  5. Li, X.; Zhu, M.; Zhao, G.; Zhou, A.; Min, L.; Liu, S.; Zhang, N.; Zhu, S.; Guo, Q.; Zhang, S.; et al. MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6. Cell Signal 2022, 93, 110286. [Google Scholar] [CrossRef]
  6. Nishimura, T.; Tamizu, E.; Uno, S.; Uwamino, Y.; Fujiwara, H.; Nishio, K.; Nakano, Y.; Shiono, H.; Namkoong, H.; Hoshino, Y.; et al. hsa-miR-346 is a potential serum biomarker of Mycobacterium avium complex pulmonary disease activity. J Infect Chemother 2017, 23, 703–708. [Google Scholar] [CrossRef]
  7. Davuluri, K.S.; Chauhan, D.S. microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during. Front Cell Infect Microbiol 2022, 12, 1009901. [Google Scholar] [CrossRef]
  8. Aguilar, C.; Cruz, A.R.; Rodrigues Lopes, I.; Maudet, C.; Sunkavalli, U.; Silva, R.J.; Sharan, M.; Lisowski, C.; Zaldívar-López, S.; Garrido, J.J.; et al. Functional screenings reveal different requirements for host microRNAs in Salmonella and Shigella infection. Nat Microbiol 2020, 5, 192–205. [Google Scholar] [CrossRef]
  9. Cassidy, B.R.; Zhang, M.; Sonntag, W.E.; Drevets, D.A. Neuroinvasive Listeria monocytogenes infection triggers accumulation of brain CD8. J Neuroinflammation 2020, 17, 259. [Google Scholar] [CrossRef]
  10. Socransky, S.S.; Haffajee, A.D.; Cugini, M.A.; Smith, C.; Kent, R.L., Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998, 25, 134–144. [Google Scholar] [CrossRef]
  11. Zhou, W.; Su, L.; Duan, X.; Chen, X.; Hays, A.; Upadhyayula, S.; Shivde, J.; Wang, H.; Li, Y.; Huang, D.; et al. MicroRNA-21 down-regulates inflammation and inhibits periodontitis. Mol Immunol 2018, 101, 608–614. [Google Scholar] [CrossRef]
  12. Xie, Y.F.; Shu, R.; Jiang, S.Y.; Liu, D.L.; Zhang, X.L. Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues. Int J Oral Sci 2011, 3, 125–134. [Google Scholar] [CrossRef]
  13. Motedayyen, H.; Ghotloo, S.; Saffari, M.; Sattari, M.; Amid, R. Evaluation of MicroRNA-146a and Its Targets in Gingival Tissues of Patients With Chronic Periodontitis. J Periodontol 2015, 86, 1380–1385. [Google Scholar] [CrossRef]
  14. Yue, J.; Song, D.; Lu, W.; Lu, Y.; Zhou, W.; Tan, X.; Zhang, L.; Huang, D. Expression Profiles of Inflammation-associated microRNAs in Periapical Lesions and Human Periodontal Ligament Fibroblasts Inflammation. J Endod 2016, 42, 1773–1778. [Google Scholar] [CrossRef]
  15. Chen, S.C.; Constantinides, C.; Kebschull, M.; Papapanou, P.N. MicroRNAs Regulate Cytokine Responses in Gingival Epithelial Cells. Infect Immun 2016, 84, 3282–3289. [Google Scholar] [CrossRef]
  16. Nahid, M.A.; Rivera, M.; Lucas, A.; Chan, E.K.; Kesavalu, L. Polymicrobial infection with periodontal pathogens specifically enhances microRNA miR-146a in ApoE-/- mice during experimental periodontal disease. Infect Immun 2011, 79, 1597–1605. [Google Scholar] [CrossRef]
  17. Aravindraja, C.; Kashef, M.R.; Vekariya, K.M.; Ghanta, R.K.; Karanth, S.; Chan, E.K.L.; Kesavalu, L. Global Noncoding microRNA Profiling in Mice Infected with Partial Human Mouth Microbes (PAHMM) Using an Ecological Time-Sequential Polybacterial Periodontal Infection (ETSPPI) Model Reveals Sex-Specific Differential microRNA Expression. Int J Mol Sci 2022, 23. [Google Scholar] [CrossRef]
  18. Godovikova, V.; Goetting-Minesky, M.P.; Timm, J.C.; Fenno, J.C. Immunotopological Analysis of the Treponema denticola Major Surface Protein (Msp). J Bacteriol 2019, 201. [Google Scholar] [CrossRef]
  19. Goetting-Minesky, M.P.; Godovikova, V.; Fenno, J.C. Approaches to Understanding Mechanisms of Dentilisin Protease Complex Expression in Treponema denticola. Front Cell Infect Microbiol 2021, 11, 668287. [Google Scholar] [CrossRef]
  20. Zeng, H.; Chan, Y.; Gao, W.; Leung, W.K.; Watt, R.M. Diversity of Treponema denticola and Other Oral Treponeme Lineages in Subjects with Periodontitis and Gingivitis. Microbiol Spectr 2021, 9, e0070121. [Google Scholar] [CrossRef]
  21. Hinson, A.N.; Hawkes, C.G.; Blake, C.S.; Fitzsimonds, Z.R.; Zhu, B.; Buck, G.; Lamont, R.J.; Miller, D.P. Treponema denticola Induces Interleukin-36gamma Expression in Human Oral Gingival Keratinocytes via the Parallel Activation of NF-kappaB and Mitogen-Activated Protein Kinase Pathways. Infect Immun 2022, 90, e0024722. [Google Scholar] [CrossRef]
  22. Ruby, J.; Martin, M.; Passineau, M.J.; Godovikova, V.; Fenno, J.C.; Wu, H. Activation of the Innate Immune System by Treponema denticola Periplasmic Flagella through Toll-Like Receptor 2. Infect Immun 2018, 86. [Google Scholar] [CrossRef] [PubMed]
  23. Nussbaum, G.; Ben-Adi, S.; Genzler, T.; Sela, M.; Rosen, G. Involvement of Toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components. Infect Immun 2009, 77, 3939–3947. [Google Scholar] [CrossRef] [PubMed]
  24. Nussbaum, G.; Shapira, L. How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 2011, 38 Suppl 11, 49–59. [Google Scholar] [CrossRef]
  25. Chukkapalli, S.S.; Rivera, M.F.; Velsko, I.M.; Lee, J.Y.; Chen, H.; Zheng, D.; Bhattacharyya, I.; Gangula, P.R.; Lucas, A.R.; Kesavalu, L. Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE(-/-) mice causally links periodontal disease and atherosclerosis. Infect Immun 2014, 82, 1959–1967. [Google Scholar] [CrossRef]
  26. Okuda, K.; Ishihara, K.; Nakagawa, T.; Hirayama, A.; Inayama, Y.; Okuda, K. Detection of Treponema denticola in atherosclerotic lesions. J Clin Microbiol 2001, 39, 1114–1117. [Google Scholar] [CrossRef] [PubMed]
  27. Mahendra, J.; Mahendra, L.; Fageeh, H.N.; Fageeh, H.I.; Ibraheem, W.; Abdulkarim, H.H.; Kanakamedala, A.; Prakash, P.; Srinivasan, S.; Balaji, T.M.; et al. miRNA-146a and miRNA-126 as Potential Biomarkers in Patients with Coronary Artery Disease and Generalized Periodontitis. Materials (Basel) 2021, 14. [Google Scholar] [CrossRef]
  28. Maixner, F.; Thomma, A.; Cipollini, G.; Widder, S.; Rattei, T.; Zink, A. Metagenomic analysis reveals presence of Treponema denticola in a tissue biopsy of the Iceman. PLoS One 2014, 9, e99994. [Google Scholar] [CrossRef] [PubMed]
  29. Tang, Z.; Cheng, X.; Su, X.; Wu, L.; Cai, Q.; Wu, H. Treponema denticola Induces Alzheimer-Like Tau Hyperphosphorylation by Activating Hippocampal Neuroinflammation in Mice. J Dent Res 2022, 101, 992–1001. [Google Scholar] [CrossRef] [PubMed]
  30. Bi, X.; Lv, X.; Liu, D.; Guo, H.; Yao, G.; Wang, L.; Liang, X.; Yang, Y. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. Cancer Gene Ther 2021, 28, 335–349. [Google Scholar] [CrossRef]
  31. Schober, A.; Nazari-Jahantigh, M.; Wei, Y.; Bidzhekov, K.; Gremse, F.; Grommes, J.; Megens, R.T.; Heyll, K.; Noels, H.; Hristov, M.; et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014, 20, 368–376. [Google Scholar] [CrossRef] [PubMed]
  32. Pan, J.; Qu, M.; Li, Y.; Wang, L.; Zhang, L.; Wang, Y.; Tang, Y.; Tian, H.L.; Zhang, Z.; Yang, G.Y. MicroRNA-126-3p/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion. Stroke 2020, 51, 619–627. [Google Scholar] [CrossRef] [PubMed]
  33. Xu, Y.; Ren, C.; Zhao, X.; Wang, W.; Zhang, N. microRNA-132 inhibits osteogenic differentiation of periodontal ligament stem cells via GDF5 and the NF-kappaB signaling pathway. Pathol Res Pract 2019, 215, 152722. [Google Scholar] [CrossRef]
  34. Xiao, Y.; Zhao, J.; Tuazon, J.P.; Borlongan, C.V.; Yu, G. MicroRNA-133a and Myocardial Infarction. Cell Transplant 2019, 28, 831–838. [Google Scholar] [CrossRef] [PubMed]
  35. Zhang, T.; Hu, J.; Wang, X.; Zhao, X.; Li, Z.; Niu, J.; Steer, C.J.; Zheng, G.; Song, G. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappaB-TNFalpha pathway. J Hepatol 2019, 70, 87–96. [Google Scholar] [CrossRef]
  36. Ell, B.; Mercatali, L.; Ibrahim, T.; Campbell, N.; Schwarzenbach, H.; Pantel, K.; Amadori, D.; Kang, Y. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell 2013, 24, 542–556. [Google Scholar] [CrossRef]
  37. Yuan, S.; Zhang, P.; Wen, L.; Jia, S.; Wu, Y.; Zhang, Z.; Guan, L.; Yu, Z.; Zhao, L. miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma. Oncogene 2021, 40, 5799–5813. [Google Scholar] [CrossRef]
  38. Perri, R.; Nares, S.; Zhang, S.; Barros, S.P.; Offenbacher, S. MicroRNA modulation in obesity and periodontitis. J Dent Res 2012, 91, 33–38. [Google Scholar] [CrossRef]
  39. Das Gupta, S.; Ciszek, R.; Heiskanen, M.; Lapinlampi, N.; Kukkonen, J.; Leinonen, V.; Puhakka, N.; Pitkanen, A. Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury. Int J Mol Sci 2021, 22. [Google Scholar] [CrossRef]
  40. Howard, S.; Richardson, S.; Benyeogor, I.; Omosun, Y.; Dye, K.; Medhavi, F.; Lundy, S.; Adebayo, O.; Igietseme, J.U.; Eko, F.O. Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection. Front Immunol 2021, 12, 625318. [Google Scholar] [CrossRef]
  41. Soofiyani, S.R.; Hosseini, K.; Soleimanian, A.; Abkhooei, L.; Hoseini, A.M.; Tarhriz, V.; Ghasemnejad, T. An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis. Microrna 2021, 10, 181–190. [Google Scholar] [CrossRef]
  42. Stoecklin-Wasmer, C.; Guarnieri, P.; Celenti, R.; Demmer, R.T.; Kebschull, M.; Papapanou, P.N. MicroRNAs and their target genes in gingival tissues. J Dent Res 2012, 91, 934–940. [Google Scholar] [CrossRef] [PubMed]
  43. Liu, X.; Yang, B.; Zhang, Y.; Guo, X.; Yang, Q.; Liu, X.; Bai, Q.; Lu, Q. miR-30a-5p inhibits osteogenesis and promotes periodontitis by targeting Runx2. BMC Oral Health 2021, 21, 513. [Google Scholar] [CrossRef]
  44. Wu, T.; Zhou, H.; Hong, Y.; Li, J.; Jiang, X.; Huang, H. miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 2012, 287, 7503–7511. [Google Scholar] [CrossRef]
  45. Wang, H.; Yan, B.; Zhang, P.; Liu, S.; Li, Q.; Yang, J.; Yang, F.; Chen, E. MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer. J Cell Physiol 2020, 235, 1469–1479. [Google Scholar] [CrossRef] [PubMed]
  46. Ji, F.; Pan, J.; Shen, Z.; Yang, Z.; Wang, J.; Bai, X.; Tao, J. The Circular RNA circRNA124534 Promotes Osteogenic Differentiation of Human Dental Pulp Stem Cells Through Modulation of the miR-496/β-Catenin Pathway. Front Cell Dev Biol 2020, 8, 230. [Google Scholar] [CrossRef]
  47. Krell, J.; Frampton, A.E.; Jacob, J.; Pellegrino, L.; Roca-Alonso, L.; Zeloof, D.; Alifrangis, C.; Lewis, J.S.; Jiao, L.R.; Stebbing, J.; et al. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. Mol Diagn Ther 2012, 16, 167–172. [Google Scholar] [CrossRef]
  48. Chen, C.; Wang, D.; Moshaverinia, A.; Liu, D.; Kou, X.; Yu, W.; Yang, R.; Sun, L.; Shi, S. Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res 2017, 27, 559–577. [Google Scholar] [CrossRef] [PubMed]
  49. Liu, Y.; Jiang, K.; Zhi, T.; Xu, X. miR-720 is a key regulator of glioma migration and invasion by controlling TARSL2 expression. Hum Cell 2021, 34, 1504–1516. [Google Scholar] [CrossRef] [PubMed]
  50. Zeng, J.; Wang, L.; Zhao, J.; Zheng, Z.; Peng, J.; Zhang, W.; Wen, T.; Nie, J.; Ding, L.; Yi, D. MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR. Hum Cell 2021, 34, 1388–1397. [Google Scholar] [CrossRef]
  51. Pankratz, F.; Hohnloser, C.; Bemtgen, X.; Jaenich, C.; Kreuzaler, S.; Hoefer, I.; Pasterkamp, G.; Mastroianni, J.; Zeiser, R.; Smolka, C.; et al. MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy. Circ Res 2018, 122, 417–432. [Google Scholar] [CrossRef] [PubMed]
  52. Smolka, C.; Schlösser, D.; Koentges, C.; Tarkhnishvili, A.; Gorka, O.; Pfeifer, D.; Bemtgen, X.; Asmussen, A.; Groß, O.; Diehl, P.; et al. Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36. FASEB J 2021, 35, e21956. [Google Scholar] [CrossRef] [PubMed]
  53. Li, Q.; Xu, Y.; Lv, K.; Wang, Y.; Zhong, Z.; Xiao, C.; Zhu, K.; Ni, C.; Wang, K.; Kong, M.; et al. Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates. Sci Transl Med 2021, 13. [Google Scholar] [CrossRef]
  54. Liu, X.; He, Y.; Feng, Z.; Sheng, J.; Dong, A.; Zhang, M.; Cao, L. miR-345-5p regulates adipogenesis via targeting VEGF-B. Aging (Albany NY) 2020, 12, 17114–17121. [Google Scholar] [CrossRef]
  55. Scholtz, B.; Horváth, J.; Tar, I.; Kiss, C.; Márton, I.J. Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma. Pathogens 2022, 11. [Google Scholar] [CrossRef]
  56. Amaral, S.A.; Pereira, T.S.F.; Brito, J.A.R.; Cortelli, S.C.; Cortelli, J.R.; Gomez, R.S.; Costa, F.O.; Miranda Cota, L.O. Comparison of miRNA expression profiles in individuals with chronic or aggressive periodontitis. Oral Dis 2019, 25, 561–568. [Google Scholar] [CrossRef]
  57. Nik Mohamed Kamal, N.N.S.; Awang, R.A.R.; Mohamad, S.; Shahidan, W.N.S. Plasma- and Saliva Exosome Profile Reveals a Distinct MicroRNA Signature in Chronic Periodontitis. Front Physiol 2020, 11, 587381. [Google Scholar] [CrossRef]
  58. Moradi, N.; Fadaei, R.; Haqgou, M.; Barez, S.R.; Kargasheh, F.B.; Shanaki, M.; Dilmaghani, N.A. Emerging Role of miR-372 and miR-101a in Head and Neck Squamous Cell Carcinoma. Clin Lab 2020, 66. [Google Scholar] [CrossRef]
  59. Liang, R.F.; Li, M.; Yang, Y.; Wang, X.; Mao, Q.; Liu, Y.H. Circulating miR-128 as a potential diagnostic biomarker for glioma. Clin Neurol Neurosurg 2017, 160, 88–91. [Google Scholar] [CrossRef] [PubMed]
  60. Yu, X.; Zhai, R.; Hua, B.; Bao, L.; Wang, D.; Li, Y.; Yao, W.; Fan, H.; Hao, C. miR-let-7d attenuates EMT by targeting HMGA2 in silica-induced pulmonary fibrosis. RSC Adv 2019, 9, 19355–19364. [Google Scholar] [CrossRef]
  61. Dai, T.; Zhao, X.; Li, Y.; Yu, L.; Li, Y.; Zhou, X.; Gong, Q. miR-423 Promotes Breast Cancer Invasion by Activating NF-kappaB Signaling. Onco Targets Ther 2020, 13, 5467–5478. [Google Scholar] [CrossRef] [PubMed]
  62. Liu, D.; Tang, H.; Li, X.Y.; Deng, M.F.; Wei, N.; Wang, X.; Zhou, Y.F.; Wang, D.Q.; Fu, P.; Wang, J.Z.; et al. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease. Mol Ther 2017, 25, 752–764. [Google Scholar] [CrossRef]
  63. Li, C.; Yue, J.; Huang, X.; Chen, M.; Gao, J.; Wu, B. miR-21 and miR-101 regulate PLAP-1 expression in periodontal ligament cells. Mol Med Rep 2012, 5, 1340–1346. [Google Scholar] [CrossRef]
  64. Xu, H.; Zhang, J.; Shi, X.; Li, X.; Zheng, C. NF-kappaB inducible miR-30b-5p aggravates joint pain and loss of articular cartilage via targeting SIRT1-FoxO3a-mediated NLRP3 inflammasome. Aging (Albany NY) 2021, 13, 20774–20792. [Google Scholar] [CrossRef] [PubMed]
  65. Shen, Y.F.; Zhu, Z.Y.; Qian, S.X.; Xu, C.Y.; Wang, Y.P. miR-30b protects nigrostriatal dopaminergic neurons from MPP(+)-induced neurotoxicity via SNCA. Brain Behav 2020, 10, e01567. [Google Scholar] [CrossRef]
  66. Di Martino, M.T.; Arbitrio, M.; Caracciolo, D.; Cordua, A.; Cuomo, O.; Grillone, K.; Riillo, C.; Carida, G.; Scionti, F.; Labanca, C.; et al. miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review. Mol Ther Nucleic Acids 2022, 27, 1191–1224. [Google Scholar] [CrossRef]
  67. Liu, Z.; Wang, B.; Guo, Q. MiR-26b-5p-modified hUB-MSCs derived exosomes attenuate early brain injury during subarachnoid hemorrhage via MAT2A-mediated the p38 MAPK/STAT3 signaling pathway. Brain Res Bull 2021, 175, 107–115. [Google Scholar] [CrossRef] [PubMed]
  68. Aravindraja, C.; Sakthivel, R.; Liu, X.; Goodwin, M.; Veena, P.; Godovikova, V.; Fenno, J.C.; Levites, Y.; Golde, T.E.; Kesavalu, L. Intracerebral but Not Peripheral Infection of Live Porphyromonas gingivalis Exacerbates Alzheimer's Disease like Amyloid Pathology in APP-TgCRND8 Mice. International Journal of Molecular Sciences 2022, 23, 3328. [Google Scholar] [CrossRef]
  69. Carè, A.; Catalucci, D.; Felicetti, F.; Bonci, D.; Addario, A.; Gallo, P.; Bang, M.L.; Segnalini, P.; Gu, Y.; Dalton, N.D.; et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13, 613–618. [Google Scholar] [CrossRef]
  70. He, B.; Xiao, J.; Ren, A.J.; Zhang, Y.F.; Zhang, H.; Chen, M.; Xie, B.; Gao, X.G.; Wang, Y.W. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 2011, 18, 22. [Google Scholar] [CrossRef]
  71. Sang, H.Q.; Jiang, Z.M.; Zhao, Q.P.; Xin, F. MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats. Biomed Pharmacother 2015, 71, 185–189. [Google Scholar] [CrossRef]
  72. Kesavalu, L.; Falk, C.W.; Davis, K.J.; Steffen, M.J.; Xu, X.; Holt, S.C.; Ebersole, J.L. Biological characterization of lipopolysaccharide from Treponema pectinovorum. Infect Immun 2002, 70, 211–217. [Google Scholar] [CrossRef]
  73. Luo, Q.; Zhu, J.; Zhang, Q.; Xie, J.; Yi, C.; Li, T. MicroRNA-486-5p Promotes Acute Lung Injury via Inducing Inflammation and Apoptosis by Targeting OTUD7B. Inflammation 2020, 43, 975–984. [Google Scholar] [CrossRef]
  74. Zhu, B.; Liu, W.; Xu, Q.; Liu, H.L. MicroRNA-486-5p functions as a diagnostic marker for carotid artery stenosis and prevents endothelial dysfunction through inhibiting inflammation and oxidative stress. Bioengineered 2022, 13, 8667–8675. [Google Scholar] [CrossRef]
  75. Marques-Rocha, J.L.; Samblas, M.; Milagro, F.I.; Bressan, J.; Martinez, J.A.; Marti, A. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J 2015, 29, 3595–3611. [Google Scholar] [CrossRef]
  76. Miklossy, J. Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease. Front Aging Neurosci 2015, 7, 46. [Google Scholar] [CrossRef] [PubMed]
  77. Miklossy, J. Bacterial Amyloid and DNA are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques. J Alzheimers Dis 2016, 53, 1459–1473. [Google Scholar] [CrossRef]
  78. Wu, L.; Su, X.; Tang, Z.; Jian, L.; Zhu, H.; Cheng, X.; Wu, H. Treponema denticola Induces Neuronal Apoptosis by Promoting Amyloid-beta Accumulation in Mice. Pathogens 2022, 11. [Google Scholar] [CrossRef] [PubMed]
  79. Pisani, F.; Pisani, V.; Arcangeli, F.; Harding, A.; Singhrao, S.K. The Mechanistic Pathways of Periodontal Pathogens Entering the Brain: The Potential Role of Treponema denticola in Tracing Alzheimer's Disease Pathology. Int J Environ Res Public Health 2022, 19. [Google Scholar] [CrossRef] [PubMed]
  80. Liu, J.; He, J.; Chen, X.; Feng, Y.; Wang, C.; Awil, M.A.; Wang, Y.; Tian, Y.; Hou, D. Cilostazol for Aneurysmal Subarachnoid Hemorrhage: An Updated Systematic Review and Meta-Analysis. Cerebrovasc Dis 2022, 51, 138–148. [Google Scholar] [CrossRef] [PubMed]
  81. Kesavalu, L.; Ebersole, J.L.; Machen, R.L.; Holt, S.C. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun 1992, 60, 1455–1464. [Google Scholar] [CrossRef] [PubMed]
  82. Kesavalu, L.; Holt, S.C.; Ebersole, J.L. In vitro environmental regulation of Porphyromonas gingivalis growth and virulence. Oral Microbiol Immunol 2003, 18, 226–233. [Google Scholar] [CrossRef]
  83. Chukkapalli, S.S.; Velsko, I.M.; Rivera-Kweh, M.F.; Zheng, D.; Lucas, A.R.; Kesavalu, L. Polymicrobial Oral Infection with Four Periodontal Bacteria Orchestrates a Distinct Inflammatory Response and Atherosclerosis in ApoE null Mice. PLoS One 2015, 10, e0143291. [Google Scholar] [CrossRef]
  84. Chukkapalli, S.S.; Velsko, I.M.; Rivera-Kweh, M.F.; Larjava, H.; Lucas, A.R.; Kesavalu, L. Global TLR2 and 4 deficiency in mice impacts bone resorption, inflammatory markers and atherosclerosis to polymicrobial infection. Mol Oral Microbiol 2017, 32, 211–225. [Google Scholar] [CrossRef] [PubMed]
  85. Rivera, M.F.; Lee, J.Y.; Aneja, M.; Goswami, V.; Liu, L.; Velsko, I.M.; Chukkapalli, S.S.; Bhattacharyya, I.; Chen, H.; Lucas, A.R.; et al. Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice. PLoS One 2013, 8, e57178. [Google Scholar] [CrossRef]
  86. Velsko, I.M.; Chukkapalli, S.S.; Rivera-Kweh, M.F.; Zheng, D.; Aukhil, I.; Lucas, A.R.; Larjava, H.; Kesavalu, L. Periodontal pathogens invade gingiva and aortic adventitia and elicit inflammasome activation in alphavbeta6 integrin-deficient mice. Infect Immun 2015, 83, 4582–4593. [Google Scholar] [CrossRef] [PubMed]
  87. Chukkapalli, S.S.; Rivera-Kweh, M.F.; Velsko, I.M.; Chen, H.; Zheng, D.; Bhattacharyya, I.; Gangula, P.R.; Lucas, A.R.; Kesavalu, L. Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers. Pathog Dis 2015, 73. [Google Scholar] [CrossRef] [PubMed]
  88. Aravindraja, C.; Vekariya, K.M.; Botello-Escalante, R.; Rahaman, S.O.; Chan, E.K.L.; Kesavalu, L. Specific microRNA Signature Kinetics in Porphyromonas gingivalis-Induced Periodontitis. Int J Mol Sci 2023, 24. [Google Scholar] [CrossRef]
  89. Cioce, M.; Rutigliano, D.; Puglielli, A.; Fazio, V.M. Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells. Cancer Drug Resist 2022, 5, 814–828. [Google Scholar] [CrossRef]
  90. Vlachos, I.S.; Zagganas, K.; Paraskevopoulou, M.D.; Georgakilas, G.; Karagkouni, D.; Vergoulis, T.; Dalamagas, T.; Hatzigeorgiou, A.G. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 2015, 43, W460–466. [Google Scholar] [CrossRef]
  91. Huang, H.Y.; Lin, Y.C.; Cui, S.; Huang, Y.; Tang, Y.; Xu, J.; Bao, J.; Li, Y.; Wen, J.; Zuo, H.; et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 2022, 50, D222–D230. [Google Scholar] [CrossRef] [PubMed]
Preprints 79334 g001
Figure 1. Gingival infection of T. denticola significantly induced (ABR). A. Schematic diagram of the experimental design depicting the monobacterial T. denticola infection (4 days per week on every alternate week), plaque sampling for PCR and euthanasia. B. Representative images showing horizontal ABR (mandible lingual view) of T. denticola-infected and sham-infected mice with the area of bone resorption outlined from the alveolar bone crest (ABC) to the cementoenamel junction (CEJ). C. Morphometric analysis of the mandible and maxillary ABR in mice. A significant increase in ABR was observed in T. denticola -infected mice compared to sham-infected mice at both 8-weeks and 16-weeks infected mice (****, p < 0.0001; ***, adjusted p-value=0.0004; ordinary two-way ANOVA). Data points and error bars are mean± SEM (n=10).
Figure 1. Gingival infection of T. denticola significantly induced (ABR). A. Schematic diagram of the experimental design depicting the monobacterial T. denticola infection (4 days per week on every alternate week), plaque sampling for PCR and euthanasia. B. Representative images showing horizontal ABR (mandible lingual view) of T. denticola-infected and sham-infected mice with the area of bone resorption outlined from the alveolar bone crest (ABC) to the cementoenamel junction (CEJ). C. Morphometric analysis of the mandible and maxillary ABR in mice. A significant increase in ABR was observed in T. denticola -infected mice compared to sham-infected mice at both 8-weeks and 16-weeks infected mice (****, p < 0.0001; ***, adjusted p-value=0.0004; ordinary two-way ANOVA). Data points and error bars are mean± SEM (n=10).
Preprints 79334 g001
Preprints 79334 g002
Figure 2. Differentially expressed (DE) miRNAs in T. denticola-infected mandibles (8- and 16-weeks). A. The volcano plot depicts the upregulated (green) and downregulated (red) miRNAs that showed a fold difference of ±1.1 with p-value of < 0.05. The log2 fold change (FC) is on the x-axis, and the negative log of the p-value is on the y-axis. The black dots represent the miRNAs that do not pass the filter parameters. Nine significant upregulated miRNAs and eighteen downregulated miRNAs were identified in 16-weeks-T. denticola-infected mice (n=10). B. Venn diagram analysis illustrate the distribution of DE miRNAs in 8-weeks and 16-weeks infection with T. denticola . This analysis shows that only one miRNAs, miRNA-126-5p was commonly upregulated in both 8- and 16-weeks infected mice. All other upregulated and downregulated miRNAs were unique to the 8- and 16-weeks infected mice.
Figure 2. Differentially expressed (DE) miRNAs in T. denticola-infected mandibles (8- and 16-weeks). A. The volcano plot depicts the upregulated (green) and downregulated (red) miRNAs that showed a fold difference of ±1.1 with p-value of < 0.05. The log2 fold change (FC) is on the x-axis, and the negative log of the p-value is on the y-axis. The black dots represent the miRNAs that do not pass the filter parameters. Nine significant upregulated miRNAs and eighteen downregulated miRNAs were identified in 16-weeks-T. denticola-infected mice (n=10). B. Venn diagram analysis illustrate the distribution of DE miRNAs in 8-weeks and 16-weeks infection with T. denticola . This analysis shows that only one miRNAs, miRNA-126-5p was commonly upregulated in both 8- and 16-weeks infected mice. All other upregulated and downregulated miRNAs were unique to the 8- and 16-weeks infected mice.
Preprints 79334 g002
Preprints 79334 g003
Figure 3. Predicted functional pathway analysis of DE miRNAs from T. denticola-infected mandibles. Bubble Plot of KEGG analysis on predicted target genes of DE miRNAs in T. denticola-infected mice compared to sham-infected mice. The KEGG pathways are displayed on the y-axis, and the x-axis represents the false discovery rate (FDR) which means the probability of false positives in all tests. The size and color of dots represent the number of predicted genes and corresponding p-value, respectively. Fourteen DE miRs were shown to be involved in bacterial invasion of epithelial cells.
Figure 3. Predicted functional pathway analysis of DE miRNAs from T. denticola-infected mandibles. Bubble Plot of KEGG analysis on predicted target genes of DE miRNAs in T. denticola-infected mice compared to sham-infected mice. The KEGG pathways are displayed on the y-axis, and the x-axis represents the false discovery rate (FDR) which means the probability of false positives in all tests. The size and color of dots represent the number of predicted genes and corresponding p-value, respectively. Fourteen DE miRs were shown to be involved in bacterial invasion of epithelial cells.
Preprints 79334 g003
Preprints 79334 g004
Figure 4. Significantly differentially expressed genes (identified by KEGG) involved in the bacterial invasion of epithelial cells signaling pathway. Red boxes indicate significantly increased expression based on miRNA profiles from Nanostring analysis. Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells. Invasive bacteria induce their own uptake by non-phagocytic host cells (e.g. epithelial cells) using two mechanisms referred to as the zipper model and trigger model. Listeria, Staphylococcus, Streptococcus, and Yersinia are examples of bacteria that can enter using the zipper model. These bacteria express proteins on their surfaces that interact with cellular receptors, initiating signaling cascades that result in close apposition of the cellular membrane around the entering bacteria. Shigella and Salmonella are the examples of bacteria entering cells using the trigger model.
Figure 4. Significantly differentially expressed genes (identified by KEGG) involved in the bacterial invasion of epithelial cells signaling pathway. Red boxes indicate significantly increased expression based on miRNA profiles from Nanostring analysis. Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells. Invasive bacteria induce their own uptake by non-phagocytic host cells (e.g. epithelial cells) using two mechanisms referred to as the zipper model and trigger model. Listeria, Staphylococcus, Streptococcus, and Yersinia are examples of bacteria that can enter using the zipper model. These bacteria express proteins on their surfaces that interact with cellular receptors, initiating signaling cascades that result in close apposition of the cellular membrane around the entering bacteria. Shigella and Salmonella are the examples of bacteria entering cells using the trigger model.
Preprints 79334 g004
Table 1. Gingival plaque samples positive for T. denticola gDNA by PCR.
Table 1. Gingival plaque samples positive for T. denticola gDNA by PCR.
Group/Bacteria/Weeks Positive gingival plaque samples (n=10)
2 weeks 4 weeks 6 weeks 12 weeks
Group I/ T. denticola ATCC 35405 [8-weeks] 1/10 10/10 NC ---
Group II/ T. denticola ATCC 35405 [16-weeks] 1/10 10/10 NC 10/10
Group III/ Sham-infection [8-weeks] 0/10 NC NC ---
Group IV/ Sham-infection [16-weeks] 0/10 NC NC 0/10
Total numbers of gingival plaque samples that were collected after infections (2, 4, 6, and 12 weeks) following T. denticola gingival infections and were positive as determined by PCR analysis. NC – not collected to allow bacterial biofilm to adhere to gingival surface, invade epithelial cells, and multiply. The first value corresponds to the number of mice that tested positive for bacterial genomic DNA and the second value corresponds to the total number of mice in the group.
Table 2. Distribution of T. denticola genomic DNA of periodontal bacteria to distal organs.
Table 2. Distribution of T. denticola genomic DNA of periodontal bacteria to distal organs.
Positive systemic tissue specimens for T. denticola (16-weeks) (n=5 Males and 5 Females)
Bacterial infection Sex (M/F) Heart Lungs Kidney Liver Spleen
T. denticola M 0 0 0 0 0
F 0 2 0 0 0
To analyze the bacterial systemic infection, total genomic DNA from an aliquot of the mouse heart (comprising the right atrium and right ventricle), lungs, kidney, liver and spleen was extracted. The extracted genomic DNA was examined for the presence of bacterial DNA through the T. denticola-specific 16S rRNA gene primers. 40% of the female mice infected with T. denticola at 16-weeks demonstrated bacterial dissemination in their lung tissues.
Table 3. Differentially expressed miRNAs during 8- and 16-weeks of T. denticola infection.
Table 3. Differentially expressed miRNAs during 8- and 16-weeks of T. denticola infection.
Weeks/Infection/Sex Upregulated miRNAs (p<0.05) Downregulated miRNAs (p<0.05)
8 Weeks - T. denticola infected
Vs
8 Weeks - Sham infection (n=10)		 13 (miR-133a, miR-126-5p) 25 (miR-375, miR-34b-5p)
8 Weeks - T. denticola infected
Female Vs Male (n=5)		 128 14
16 Weeks - T. denticola infected
Vs
16 Weeks - Sham infection (n=10)		 13 (miR-486, miR-126-3p, miR-126-5p) 19
16 Weeks - T. denticola infected
Female Vs Male (n=5)		 9 8
8 Weeks - T. denticola infected
Vs
16 Weeks - T. denticola infected		 9 (miR-126-5p) 19
The number of differentially expressed (DE) miRNAs were shown for T. denticola infected mice after 8- and 16-weeks infections. The commonly expressed miRNAs between 8 weeks and 16 weeks bacterial infected groups are shown in brackets. Most of the miRNAs expressed in bacterial infected group were unique and specific to the 8- and 16-weeks infections.
Table 4. Upregulated miRNAs, reported functions, and target genes.
Table 4. Upregulated miRNAs, reported functions, and target genes.
Upregulated miRNAs in 8-weeks T. denticola infection
miRs Fold change p-value Reported functions Number of Target Genes
mmu-miR-133a 1.83 0.0176 Abundant in heart and it is shown to be involved in the early pathological cascade of myocardial infarction [34]. 1426 (e.g., Med13, Rrp8, Cup, Srrm2, Wipi2, Dlc1, Tgfb2, Rsbn1l, Kat6b, Pold2)
mmu-miR-378 1.57 0.0198 Major role in hepatic inflammation and fibrosis by targeting NFκB-TNFα axis [35]. Major secreted biomarkers for osteolytic bone metastasis [36]. Expressed greater degree in microvesicles of osteoclasts. --
mmu-miR-22 1.55 0.0012 Promotes cell differentiation, tumor initiation, progression, and metastasis by maintaining Wnt/β-catenin signaling and cancer stem cells function [37]. Observed in the inflammatiory mouse lung and brain tissues of Polyinosinic-polycytidylic acid treated mice. Upregulated in the periodontal disease and obesity [38]. 2150 (e.g., Arl8b, Syne1, Mbp, Med13, Srrm2, Tpm3, Inpp1, Bin1, Seam3d, Abcg5)
mmu-miR-136 1.37 0.0066 Potential miRNA biomarker in both experimental and human mild traumatic brain injury [39]. 809 (e.g., Arl8b, Syne1, Med13, Mreg, Rsbn1l, Erc2, Akap8, Sf3a1, Akt2, Apob)
mmu-miR-2135 1.36 0.0389 Upregulated in chlamydial infection in experimental mice [40]. --
mmu-miR-451 1.33 0.0191 Strongly dysregulated in lung cancer and and important miRNA for lung tumor progression [41]. Strongly upregulated in the gingival tissue of Periodontitis [42].
mmu-miR-30a 1.28 0.0254 Overexpressed in gingival tissues in periodontitis patients that inhibits osteogenesis and promotes periodontitis [43].
mmu-miR-30c 1.25 0.0401 Negative regulator of osteogenic differentiation and bone morphometric protein (BMP)-induced osteogenic differentiation [44].
mmu-miR-496 1.22 0.0020 Tumor metastasis mediated by Wnt signaling pathways in colorectal cancer [45]. Enforced expression of miR-496 reversed the osteogenesis [46].
mmu-miR-126-5p 1.21 0.0148 Major role in ovarian cancer by promoting chemoresistance of ovarian cancer cells [30]. Attenuates blood-brain barrier after ischemic stroke [32].
mmu-miR-151-5p 1.15 0.0088 Associated with metastasis in breast cancer and hepatocellular carcinoma [47]. Is a therapeutic target for systemic sclerosis [48].
mmu-miR-720 1.14 0.0111 Promotes glioma growth and upregulates invasion-related genes. Significantly upregulated in glioma tissues and cells [49].
mmu-miR-100 1.11 0.0484 Overexpressed in hypertrophic hearts and promotes pathogenesis of cardiac hypertrophy through activation of autophagy [50], a potential protective anti-athero-miR [51]. Modulator of cardiac metabolism, ROS production and protective effect in pressure-overload-induced cardiac stress and heart failure [52].
Upregulated miRNAs in 16-weeks T. denticola infection
mmu-miR-486 1.29 0.0350 Promotes cardiac angiogenesis through fibroblastic MMP19-VEGFA cleavage signaling pathway [53]. Upregulated in chronic myeloid leukemia. Strongly upregulated in the gingival tissue of Periodontitis [42]. --
mmu-miR-126-5p 1.28 0.0050 Major role in ovarian cancer by promoting chemoresistance of ovarian cancer cells [30]. Attenuates blood-brain barrier after ischemic stroke [32]. Promotes the proliferation of endothelial cells and limiting the atherosclerosis [31]. --
mmu-miR-345-5p 1.23 0.0004 Overexpression of miR-345 reduce lipid accumulation in adipocytes and their related genes involved in lipogenic transcription, fatty acid synthesis and fatty acid transport [54]. Consistently upregulated salivary biomarkers for oral squamous cell carcinoma [55]. 124 (e.g., Dlc1, Rarg, Glu1, Dmgdh, Afmid, Acp2, Inpp5b, Eng, Caprin1, Senp2)
mmu-miR-132 1.21 0.0100 Inhibits differentiation of periodontal ligament cells into osteoblasts [33]. 482 (e.g., Tthdf3, Wipf, Mapk1, Nek7, Selk, Tspy13, Hus1, Stk35, Arid5b, Plek)
mmu-miR-126-3p 1.2 0.0432 Significantly upregulated in the gingival tissues of chronic and aggressive periodontitis patients [56] and saliva samples of chronic periodontitis [57]. --
mmu-miR-101a 1.2 0.0460 Decreased expression observed in serum samples in patients with head and neck squamous cell carcinoma (HNSCC) [58].
mmu-miR-128 1.18 0.026 Overexpressed in glioma and a potential noninvasive biomarker to diagnose glioma [59].
mmu-let-7d 1.17 0.0044 Attenuates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis [60].
mmu-miR-423-5p 1.17 0.0199 Overexpression of miR-423-5p induced breast cancer cell invasion through NFκB signaling pathway [61].
mmu-miR-101b 1.17 0.0421 Play a critical mediator of Tauopathy and Dendritic abnormalities in Alzheimer’s Disease progression [62,63].
mmu-miR-30b 1.16 0.0453 Overexpressed in osteoarthritis (OA) patients, OA rats and aggravates joint pain and loss of articular cartilage [64,65].
mmu-miR-221 1.14 0.0367 Oncogenic miRNA that is involved in many hematologic and solid malignancies and some non-malignant diseases [66].
mmu-miR-26b 1.08 0.0442 Inhibit M1 polarization of microglia by inactivating toll-like receptor pathway [67].
Details of the target genes were given for the top five significantly expressed miRNAs in both 8-weeks and 16-weeks infected mice mandibles.
Table 5. List of predicted miRNAs and their number of target genes involved in T. denticola-mediated invasion of epithelial cells.
Table 5. List of predicted miRNAs and their number of target genes involved in T. denticola-mediated invasion of epithelial cells.
miRNAs Fold change p-value # of genes List of genes
miR-22* 1.55 0.0011 13 Cbl, Pik3r1, Pik3r3, Ctnna1, Bcar1, Sept8, Dnm1, Wasf2, Rhoa, Actb, Crkl, Rac1, Cav3.
miR-30a 1.28 0.0254 10 Cblb, Pik3r1, Ctnna1, Sept8, Sept2, Wasl, Crk, Rac1, Itgb1, Pik3cd.
miR-30c 1.25 0.0401 10 Cblb, Pik3r1, Ctnna1, Sept8, Sept2, Wasl, Crk, Rac1, Itgb1, Pik3cd.
miR-345-5p* 1.23 0.0004 1 Sept2.
miR-132 1.21 0.0100 7 Cblb, Cltc, Sept2, Actb, Arpc4, Crk, Sept11.
miR-101a 1.2 0.0461 16 cbl, Cblb, Sept8, Cltc, Ctnna2, Rhoa, Actb, Sept6, Crk, Cd2ap, Sept11, Itgb1, Elmo1, Met, Cdc42, Cav3.
miR-128 1.18 0.0261 9 Rhog, Pik3r1, Sept8, Dnm1, Wasf2, Sept2, Gab1, Cd2ap, Met.
let-7d 1.17 0.0044 4 Rhog, Cltc, Fn1, Met.
miR-101b 1.17 0.0421 3 Cltc, Actb, Met.
miR-30b 1.16 0.0453 9 Pik3r1, Ctnna1, Cblb, WasI, Sept2, Rac1, Crk, Itgb1, Pik3cd.
miR-221 1.14 0.0367 9 Pik3r1, Pik3r3, DNM2, Ptk2, Cttn, Gab1, Crk, Cd2ap, Itgb1.
miR-26b 1.08 0.0442 8 Pik3r3, Cblb, Cltc, Itga5, Sept6, Rac1, Pik3cb, Itgb1.
miR-133a 1.83 0.0176 6 Ctnna1, Bcar1, Sept8, WasI, Cd2ap, Arpc5.
miR-136 1.37 0.0066 3 Sept3, Dnma, Crk.
Fourteen miRNAs were found to be involved in the bacterial invasion of epithelial cells in mice mandibles infected with T. denticola. *indicates miRNAs that are highly expressed during 8 weeks of T. denticola infection. *indicates miRNAs that are highly expressed during 16 weeks of T. denticola infection.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Alerts
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2025 MDPI (Basel, Switzerland) unless otherwise stated